Profil
Xiao Xu is the founder of ACEA Therapeutics, Inc. Prior to founding ACEA Therapeutics, Dr. Xu worked as a Director of Research & Development at Ngen, Inc. and as the President, Chief Executive & Financial Officer at ACEA Biosciences, Inc. Additionally, Dr. Xu worked as a Principal at The University of California, San Francisco.
Postes actifs de Xiao Xu
| Sociétés | Poste | Début |
|---|---|---|
ACEA Therapeutics, Inc.
 ACEA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acea Therapeutics, Inc. provides health care services. It specializes in lung cancer, lupus and lymphoma treatments. The company was founded by Xiao Xu and Xiaobo Wang is headquartered in San Diego, CA. | Fondateur | - |
Anciens postes connus de Xiao Xu
| Sociétés | Poste | Fin |
|---|---|---|
| NGEN INC | Directeur Technique/Scientifique/R&D | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
ACEA Biosciences, Inc.
 ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Directeur Général | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
ACEA Biosciences, Inc.
ACEA Biosciences, Inc. BiotechnologyHealth Technology ACEA Biosciences, Inc. develops bio-sensor platform based on microelectronic technologies. The firm pioneers in development and commercialization of innovative cell analysis instrumentation for life sciences, and is also engaged in drug discovery and pharmaceutical development. Its xCELLigence impedance-based, label-free, real-time cell analysis systems and NovoCyte benchtop flow cytometers are used in preclinical drug discovery and development, toxicology, safety pharmacology, disease studies, and basic academic research. The company was founded in 2002 and is headquartered in San Diego, CA. | Health Technology |
Ngen, Inc.
 Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
ACEA Therapeutics, Inc.
ACEA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acea Therapeutics, Inc. provides health care services. It specializes in lung cancer, lupus and lymphoma treatments. The company was founded by Xiao Xu and Xiaobo Wang is headquartered in San Diego, CA. | Health Technology |
